Obesity and thyroid hormone

George A. Bray
{"title":"Obesity and thyroid hormone","authors":"George A. Bray","doi":"10.1016/S0362-5486(77)80006-X","DOIUrl":null,"url":null,"abstract":"<div><p>The actions of thyroid hormone in the obese patient appear to be qualitatively similar to the effects in normal weight individuals, although there may be some small quantitative differences in the magnitude of the response. These effects include an increase in metabolic requirements, an increase in turnover of protein, fatty acids and calcium, and modification of enzymatic and hormonal systems.</p><p>The decision as to whether thyroid is useful in the treatment of an obese patient depends on the particular question. If the patient is clinically or chemically hypothyroid, there is little question that its use is necessary. For the euthyroid obese patient, however, there may also be a place for the judicious use of thyroid hormones. Such a situation might arise during profound caloric restriction when metabolic rate is known to decline. In this situation, the appropriate doses of thyroid hormone may obviate this physiologic adaption of caloric deprivation.</p></div>","PeriodicalId":101017,"journal":{"name":"Pharmacology & Therapeutics. Part C: Clinical Pharmacology and Therapeutics","volume":"2 2","pages":"Pages 205-214"},"PeriodicalIF":0.0000,"publicationDate":"1977-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0362-5486(77)80006-X","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacology & Therapeutics. Part C: Clinical Pharmacology and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S036254867780006X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

The actions of thyroid hormone in the obese patient appear to be qualitatively similar to the effects in normal weight individuals, although there may be some small quantitative differences in the magnitude of the response. These effects include an increase in metabolic requirements, an increase in turnover of protein, fatty acids and calcium, and modification of enzymatic and hormonal systems.

The decision as to whether thyroid is useful in the treatment of an obese patient depends on the particular question. If the patient is clinically or chemically hypothyroid, there is little question that its use is necessary. For the euthyroid obese patient, however, there may also be a place for the judicious use of thyroid hormones. Such a situation might arise during profound caloric restriction when metabolic rate is known to decline. In this situation, the appropriate doses of thyroid hormone may obviate this physiologic adaption of caloric deprivation.

肥胖与甲状腺激素
在肥胖患者中,甲状腺激素的作用在质量上似乎与正常体重的人相似,尽管在反应的幅度上可能存在一些小的数量差异。这些影响包括代谢需求的增加,蛋白质、脂肪酸和钙的周转增加,酶和激素系统的改变。关于甲状腺是否对治疗肥胖患者有用的决定取决于具体的问题。如果患者临床上或化学性甲状腺功能减退,毫无疑问,它的使用是必要的。然而,对于甲状腺功能正常的肥胖患者,也可能需要明智地使用甲状腺激素。这种情况可能出现在深度热量限制,当代谢率已知下降。在这种情况下,适当剂量的甲状腺激素可以消除这种对热量剥夺的生理适应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信